MMC
67
2
TSN
42
3
RIG
55
-6
NRG
60
18
URBN
50
-2
GOOG
57
2
ADT
50
2
OKE
78
3
AMG
57
2
GILD
54
3
BRK.B
45
2
OI
38
-5
UHS
62
6
FFIV
69
2
GM
65
-7
VMC
60
-2
SLB
53
-3
MMM
42
5
SYK
68
4
CME
64
5
MMC
67
2
TSN
42
3
RIG
55
-6
NRG
60
18
URBN
50
-2
GOOG
57
2
ADT
50
2
OKE
78
3
AMG
57
2
GILD
54
3
BRK.B
45
2
OI
38
-5
UHS
62
6
FFIV
69
2
GM
65
-7
VMC
60
-2
SLB
53
-3
MMM
42
5
SYK
68
4
CME
64
5
Financhill
Back

ProShares UltraPro Short MidCap400 Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
5

SMDD
ProShares UltraPro Short MidCap400

Last Price:
7.26
Seasonality Move:
-18.9%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.74
Seasonality Move:
14.88%
Sell
5
ProShares UltraPro Short MidCap400 (SMDD) is a Sell

Is ProShares UltraPro Short MidCap400 a Buy, Sell or Hold?

  • The current ProShares UltraPro Short MidCap400 [SMDD] share price is $7.18. The Score for SMDD is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • SMDD is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SMDD Stock Price Chart

What is ProShares UltraPro Short MidCap400's stock price today?

  • The ProShares UltraPro Short MidCap400 share price today is $7.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMDD is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

SMDD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.41 Sell
Relative Strength Index (14 RSI): 30.58 Sell
Chaikin Money Flow: -3510 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.63 - 9.09) Sell
Bollinger Bands (100): (8.5 - 10.66) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

SMDD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.84 Sell
20-day SMA: 8.17 Sell
50-day SMA: 8.74 Sell
200-day SMA: 10.5 Sell
8-day EMA: 7.64 Sell
20-day EMA: 8.06 Sell
50-day EMA: 8.71 Sell
200-day EMA: 10.91 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

ProShares UltraPro Short MidCap400 Earnings Growth & SMDD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

ProShares UltraPro Short MidCap400 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):